Page last updated: 2024-10-21

urea and Encapsulating Peritoneal Sclerosis

urea has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Research Excerpts

ExcerptRelevanceReference
"PPARγ inhibited high glucose-induced peritoneal fibrosis progression through elevating GLUT1 expression and repressing peritoneal mesothelial cell proliferation."1.72PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation. ( Feng, J; Gao, X; Li, J; Li, W; Li, Z; Lu, M; Meng, P; Zhang, Y, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Feng, J1
Lu, M1
Li, W1
Li, J1
Meng, P1
Li, Z1
Gao, X1
Zhang, Y1

Other Studies

1 other study available for urea and Encapsulating Peritoneal Sclerosis

ArticleYear
PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation.
    Molecular and cellular biochemistry, 2022, Volume: 477, Issue:7

    Topics: Animals; Cell Proliferation; Creatinine; Dialysis Solutions; Glucose; Glucose Transporter Type 1; Ni

2022